Literature DB >> 24013203

A new self-controlled case series method for analyzing spontaneous reports of adverse events after vaccination.

S Escolano, C Hill, P Tubert-Bitter.   

Abstract

In this paper, we propose new methods for analyzing cases of vaccine adverse events spontaneously reported to a surveillance database. The methods use the self-controlled case series approach, extended in several ways with parametric and nonparametric assumptions to account for the specific features of the data (large amount of underreporting and variation of reporting with time since vaccination). This work was motivated by the documented risk of intussusception after RotaShield vaccination (Wyeth-Lederle Vaccines, Radnor, Pennsylvania) and used worldwide spontaneous reports of intussusception occurring after Rotarix vaccination (GlaxoSmithKline Biologics, Research Triangle Park, North Carolina) collected between January 2004 and February 2010. The estimated risk during the 3- to 7-day period after vaccination was approximately 5 times higher after dose 1 of Rotarix than after dose 2, which is similar to published findings on the same topic. We undertook a large simulation study to evaluate the performance of the method in different scenarios, including its robustness to different sample sizes and time-dependent reporting functions. The bias was generally small, the type I error rate was correctly controlled, and the power to detect a risk ratio of 4 was satisfactory, provided that the sample size was over 100. The proposed methods are an effective way to explore and quantify vaccine safety signals from spontaneous reports.

Entities:  

Keywords:  adverse events; intussusception; pharmacoepidemiology; pharmacovigilance; rotavirus; self-controlled case series; spontaneous reporting; vaccines

Mesh:

Substances:

Year:  2013        PMID: 24013203     DOI: 10.1093/aje/kwt128

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  6 in total

1.  Risk of Intussusception After Rotavirus Vaccination.

Authors:  Judith Koch; Thomas Harder; Rüdiger von Kries; Ole Wichmann
Journal:  Dtsch Arztebl Int       Date:  2017-04-14       Impact factor: 5.594

2.  Adverse Drug Reaction Discovery from Electronic Health Records with Deep Neural Networks.

Authors:  Wei Zhang; Peggy Peissig; Zhaobin Kuang; David Page
Journal:  Proc ACM Conf Health Inference Learn (2020)       Date:  2020-04

3.  Venous Thromboembolism following Two Doses of COVID-19 mRNA Vaccines in the US Population, 2020-2022.

Authors:  Daoyuan Lai; Yan Dora Zhang; Junfeng Lu
Journal:  Vaccines (Basel)       Date:  2022-08-15

4.  Accounting for indirect protection in the benefit-risk ratio estimation of rotavirus vaccination in children under the age of 5 years, France, 2018.

Authors:  Sylvie Escolano; Judith E Mueller; Pascale Tubert-Bitter
Journal:  Euro Surveill       Date:  2020-08

5.  Association between influenza and the incidence rate of new-onset type 1 diabetes in Japan.

Authors:  Yuichi Nishioka; Tatsuya Noda; Sadanori Okada; Tomoya Myojin; Shinichiro Kubo; Tsuneyuki Higashino; Hiroki Nakajima; Takehiro Sugiyama; Hitoshi Ishii; Tomoaki Imamura
Journal:  J Diabetes Investig       Date:  2021-04-03       Impact factor: 4.232

Review 6.  Established and new rotavirus vaccines: a comprehensive review for healthcare professionals.

Authors:  Volker Vetter; Robert C Gardner; Serge Debrus; Bernd Benninghoff; Priya Pereira
Journal:  Hum Vaccin Immunother       Date:  2021-02-19       Impact factor: 3.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.